Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 3 Next »


Attendees

Name

Affiliation

Shane, John, Tracie, Cary, Pawan, Steve White, Lee Wise, Ken

Agenda and Minutes

Document any tasks here, Document any decisions on group page

Agenda Item

Lead

Minutes

  • Connect, ah-ha’s, high level key points;

  • IHE Update;

  • good progress; Shane participating on Board; good traction from BPM+ participation; bringing forth thought leadership

  • IHE Connect-a-thon in March; four slots for BPM+ in Education arena: short (2 hr) jump start live session (to be recorded); Advance Dir and Consents and TBD deep dive sessions; 10 minute TED Talk from Shane

  • One of the King Maker bodies; and connection to HIMSS

  • Link to program is needed (link on Events Page live now)

  • They are leaning into this

  • Jason Smith, Robert and Denis met on the IHE Jump Start Session; meeting again today; prompt for access to tools later, forthcoming

  • 2021 Key Objectives (PRODUCT – IMPLEMENTATION – OUTREACH):

  • Achieving funding goals:

    • Funded project for BPM+ Health; advocate for this;

    • Funding for more development of protocols and workflows;

    • At least one pilot in 2021;

  • Drive awareness in marketplace (influence):

    • Publish a peer-reviewed paper (at least one guideline);

    • Get on radar at policy level;

  • Find the right membership balance:

    • Understand the right makeup;

    • Ensure everyone has/knows role;

  • Hone stakeholder network:

    • Relationship with FDA (focus on compliance);

    • ACEP supportive of work with ACOG; (policy workgroup?)

  • Tactical efforts:

    • Finish the two protocols previously started;

    • Identify more collaborative pathways;

    • Get BPM+ written-into next CMS ONC final role for interoperability;

  • 2021 Actions, Leads and Milestone/Timeline to Achieve Objectives;

  • AMIA Discussion Follow Up and Update;

  • Other topics:

  • March meeting;

  • Establish meeting for FDA focused discussion.

  • No labels